BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23908681)

  • 1. Human ribonuclease with a pendant poly(ethylene glycol) inhibits tumor growth in mice.
    Rutkoski TJ; Kink JA; Strong LE; Raines RT
    Transl Oncol; 2013 Aug; 6(4):392-7. PubMed ID: 23908681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.
    Rutkoski TJ; Kink JA; Strong LE; Raines RT
    Cancer Biol Ther; 2011 Aug; 12(3):208-14. PubMed ID: 21633186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of ribonuclease multimers created by site-specific covalent tethering.
    Rutkoski TJ; Kink JA; Strong LE; Schilling CI; Raines RT
    Bioconjug Chem; 2010 Sep; 21(9):1691-702. PubMed ID: 20704261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorption of poly(ethylene glycol)-modified ribonuclease A to a poly(lactide-co-glycolide) surface.
    Daly SM; Przybycien TM; Tilton RD
    Biotechnol Bioeng; 2005 Jun; 90(7):856-68. PubMed ID: 15841471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the heat resistance of ribonuclease A by the addition of poly(N,N-diethylaminoethyl methacrylate)-graft-poly(ethylene glycol) (PEAMA-g-PEG).
    Ganguli S; Yoshimoto K; Tomita S; Sakuma H; Matsuoka T; Shiraki K; Nagasaki Y
    Macromol Biosci; 2010 Aug; 10(8):853-9. PubMed ID: 20301119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice.
    Soucek J; Poucková P; Strohalm J; Plocová D; Hlousková D; Zadinová M; Ulbrich K
    J Drug Target; 2002 May; 10(3):175-83. PubMed ID: 12075818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
    Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
    J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
    Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
    Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
    Lu ZX; Liu LT; Qi XR
    Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA.
    Kano A; Moriyama K; Yamano T; Nakamura I; Shimada N; Maruyama A
    J Control Release; 2011 Jan; 149(1):2-7. PubMed ID: 20005270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling of the antitumoral enzyme bovine seminal ribonuclease to polyethylene glycol chains increases its systemic efficacy in mice.
    Michaelis M; Cinatl J; Cinatl J; Pouckova P; Langer K; Kreuter J; Matousek J
    Anticancer Drugs; 2002 Feb; 13(2):149-54. PubMed ID: 11901307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hyaluronidase and PEG chain conjugation on the biologic and antitumor activity of RNase A.
    Matousek J; Poucková P; Hlousková D; Zadinová M; Soucek J; Skvor J
    J Control Release; 2004 Feb; 94(2-3):401-10. PubMed ID: 14744490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargeting.
    Caliceti P; Chinol M; Roldo M; Veronese FM; Semenzato A; Salmaso S; Paganelli G
    J Control Release; 2002 Sep; 83(1):97-108. PubMed ID: 12220842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
    Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
    ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.